Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior ...

Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to ...

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, ...

As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing ...

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met ...

Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though ...

CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data ...

Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those ...

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and ...

After walking alone in Chicago’s Cancer Survivor’s Walk, I found strength, healing and a renewed commitment to live fully and authentically — starting now.